You are required to be logged in to access the full website
Click here if you have forgotten your username or password
17 March 2026 - US biopharmaceutical company Sentynl Therapeutics Inc, a wholly-owned subsidiary of Zydus Lifesciences Limited, announced on Monday that it has signed an agreement with PRG S&T, a Korea-based developer of medicine for rare genetic...
17 March 2026 - ONL Therapeutics Inc, a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, announced on Monday that the first European participant has been randomised in the...
17 March 2026 - Laronix Inc, a commercial-stage medical technology company involved in voice restoration technologies, and the Greater Baltimore Medical Center (GBMC) announced on Monday the launch of an investigational study of Laronix MIRA Voice to...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe